Home
About Us
Our Mission
Management
Board of Directors
Science Advisors
Science & Pipeline
Overview
Neuroplasticity
DMX-1001
Alcohol use disorder
Publications
Investors & Media
Media releases
News beats
For Investors
Media contact
Contact DemeRx
DemeRx Appoints Michael Snitkovsky as COO
changes
Press Release
10 Jul at 3:05 pm
Read Article
Next Post
DemeRx Strengthens Leadership Team With Appointment of Biopharmaceutical Executive Michael Snitkovsky as Chief Operations Officer
Previous Post
DemeRx Appoints Michael Snitkovsky as Chief Operating Officer to Advance Clinical Pipeline
Menu
